Lwl. Woo et al., STEROIDAL AND NONSTEROIDAL SULFAMATES AS POTENT INHIBITORS OF STEROIDSULFATASE, Journal of medicinal chemistry, 41(7), 1998, pp. 1068-1083
Synthetic routes to potent steroidal and nonsteroidal sulfamate-based
active site-directed inhibitors of the enzyme steroid sulfatase, a top
ical target in the treatment of postmenopausal women with hormone-depe
ndent breast cancer, are described. Novel compounds were examined for
estrone sulfatase (E1-STS) inhibition in intact MCF-7 breast cancer ce
lls and placental microsomes. Reaction of the sodium salt of estrone w
ith sulfamoyl chloride gave estrone 3-O-sulfamate (EMATE, 2) which inh
ibits E1-STS activity potently (> 99% at 0.1 mu M in intact MCF-7 cell
s, IC50 = 65 PM) in a time-and concentration-dependent manner, suggest
ing that EMATE is an active site-directed inhibitor. EMATE is also act
ive in vivo orally. 5,6,7,8-Tetrahydronaphthalene 2-O-sulfamate (7) an
d its N-methylated derivatives (8 and 9) were synthesized, and 7 inhib
its the E1-STS activity in intact MCF-7 cells by 79% at 10 mu M. 4-Met
hylcoumarin 7-O-sulfamate (COUMATE) and its derivatives (14, 16, and 1
8) were prepared to extend this series of nonsteroidal inhibitors, and
COUMATE reduces the E1-STS activity in placental microsomes by >90% a
t 10 mu M. Although the orally active COUMATE is less potent than EMAT
E as an active site-directed inhibitor, it has the important advantage
of being nonestrogenic. Analogues (20, 22, 24, 26, 27, 31, 33, 39, an
d 44) of COUMATE were synthesized to study its structure-activity rela
tionships, and sulfamates of tetralones (46 and 48) and indanones (49,
51, and 53) were also prepared. While most of these compounds were fo
und to inhibit E1-STS activity less effectively than COUMATE, one anal
ogue, 3,4-dimethylcoumarin 3-O-sulfamate (24), was found to be some 12
-fold more potent than COUMATE as an E1-STS inhibitor in intact MCF-7
cells (IC50 = 30 nM for 24, cf. 380 nM for COUMATE). Hence, highly pot
ent sulfamate-based inhibitors of steroid sulfatase, such as EMATE, CO
UMATE, and 24, possess therapeutic potential and will allow the import
ance of estrogen formation in breast tumors via the E1-STS pathway to
be assessed. A pharmacophore for active site-directed sulfatase inhibi
tion is proposed.